Hospital General Universitario, Unidad de Alergología, Valencia, Spain.
Clin Exp Allergy. 2011 Sep;41(9):1297-304. doi: 10.1111/j.1365-2222.2011.03749.x. Epub 2011 Apr 11.
Limited published evidence shows oral desensitization to be a potential intervention option for cow's milk protein (CMPs) allergy.
The aim of this study was to evaluate the safety and efficacy of oral desensitization in 2-year-old children with cow's milk allergy, as a treatment alternative to elimination diet.
A total of 60 children aged 24-36 months with IgE-mediated allergy to CMPs were included in this multi-center study and were randomized into two groups. Thirty children (group A: treatment group) began oral desensitization immediately, whereas the remaining 30 (group B: control group) were kept on a milk-free diet and followed-up for 1 year.
After 1-year follow-up period, 90% of the children in group A had become completely tolerant vs. 23% of the children in group B. In group A, cow's milk skin reactivity and serum-specific IgE to milk and casein decreased significantly from the initial assessment, whereas group B showed no significant change after 1 year of follow-up. Twenty-four patients (80%) developed some reaction during the treatment period: 14 children developed moderate reaction (47%) and 10 mild reaction (33%). The most common manifestations were urticaria-angioedema, followed by cough.
In this study, oral desensitization was found to be effective in a significant percentage of 2-year-old children with cow's milk allergy. Oral desensitization appears to be efficacious as an alternative to elimination diet in the treatment of 2-year-old children with cow's milk allergy. The side-effect profile appears acceptable but requires further study.
有限的文献证据表明,口服脱敏可能是牛奶蛋白(CMP)过敏的潜在干预选择。
本研究旨在评估口服脱敏在 2 岁牛奶过敏儿童中的安全性和有效性,作为消除饮食替代疗法。
共有 60 名 24-36 个月龄、对 CMP 具有 IgE 介导过敏的儿童参与了这项多中心研究,并随机分为两组。30 名儿童(A 组:治疗组)立即开始口服脱敏,而其余 30 名儿童(B 组:对照组)继续进行无牛奶饮食,并随访 1 年。
在 1 年的随访期后,A 组 90%的儿童完全耐受,而 B 组只有 23%的儿童耐受。在 A 组中,牛奶皮肤反应性和血清特异性 IgE 对牛奶和酪蛋白的水平在初始评估后显著下降,而 B 组在 1 年后的随访中没有明显变化。24 名患者(80%)在治疗期间出现了一些反应:14 名儿童出现中度反应(47%),10 名儿童出现轻度反应(33%)。最常见的表现是荨麻疹-血管性水肿,其次是咳嗽。
在这项研究中,口服脱敏在很大比例的 2 岁牛奶过敏儿童中是有效的。口服脱敏似乎是一种有效的替代消除饮食的治疗方法,适用于 2 岁牛奶过敏儿童。副作用谱似乎可以接受,但需要进一步研究。